...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** BETonMACE Trial is Fully Enrolled and Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Message: DSMB 7th review??

This is one time I'd very much like to be wrong, its just the feeling I get based on the way the cancelling of the Futility Analysis was handled...or not handled as the case may be.  

Don struck me as very confident during his presentation in May when he said that BETonMACE is "properly powered".  I know Bear has highlighted how an SSRA is more than just a report on the "powering" (for lack of a better word) of a trial....but for me that would be the only real data point I'd be interested in at this point.  

New Message
Please login to post a reply